ReShape Lifesciences Inc. (NasdaqCM:RSLS) will look for M&A. Paul Hickey President and Chief Executive Officer said during the Second Quarter 2021 Conference Call, "We remain committed to further evaluating the potential of this product, which is backed by a strong intellectual property portfolio through a nondilutive funding strategy. Finally, we will continue to evaluate M&A opportunities that align with our commitment to the physician-led weight loss and metabolic solutions market, specifically those that can enhance our current product portfolio and be accretive to our value".